Publication | Closed Access

Dexmedetomidine attenuates the induction and reverses the progress of 6-hydroxydopamine- induced parkinsonism; involvement of KATP channels, alpha 2 adrenoceptors and anti-inflammatory mechanisms

Anti-inflammatory MechanismsNeurophysiologyMedicineNeuropharmacologyKatp Channels6-Hydroxydopamine- Induced ParkinsonismNeuroprotectionNeuroscienceNeurologyPharmacotherapyDopaminePharmacologyNeurochemistrySocial SciencesNeuropeptides